CRIS Current Research Information System

TAGLIERI, NEVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.894
AS - Asia 8.043
EU - Europa 5.808
AF - Africa 654
SA - Sud America 402
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 23.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.775
VN - Vietnam 2.704
SG - Singapore 2.075
CN - Cina 1.676
GB - Regno Unito 1.326
IT - Italia 919
DE - Germania 845
SE - Svezia 720
HK - Hong Kong 527
FR - Francia 386
IN - India 341
RU - Federazione Russa 295
BR - Brasile 283
IE - Irlanda 255
NL - Olanda 244
UA - Ucraina 233
CI - Costa d'Avorio 166
JP - Giappone 145
ZA - Sudafrica 138
TG - Togo 130
FI - Finlandia 122
SC - Seychelles 104
BG - Bulgaria 102
EE - Estonia 93
KR - Corea 92
JO - Giordania 90
NG - Nigeria 77
CA - Canada 76
PH - Filippine 71
CH - Svizzera 62
BE - Belgio 46
BD - Bangladesh 45
AR - Argentina 44
TH - Thailandia 40
PL - Polonia 39
IR - Iran 36
IQ - Iraq 29
TR - Turchia 27
MX - Messico 25
AT - Austria 24
EC - Ecuador 23
ID - Indonesia 22
TW - Taiwan 22
ES - Italia 20
PK - Pakistan 16
SA - Arabia Saudita 16
CL - Cile 15
UZ - Uzbekistan 15
CO - Colombia 14
LT - Lituania 14
RO - Romania 11
AU - Australia 10
EG - Egitto 10
HR - Croazia 8
PY - Paraguay 8
GR - Grecia 7
JM - Giamaica 6
KZ - Kazakistan 6
OM - Oman 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
LB - Libano 5
LV - Lettonia 5
MN - Mongolia 5
MY - Malesia 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
PE - Perù 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
DZ - Algeria 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
Totale 23.796
Salva come PNG Salva come JPEG
Città #
Singapore 1.436
Southend 1.113
Ashburn 1.033
Fairfield 748
Chandler 706
Ho Chi Minh City 627
Hanoi 560
San Jose 524
Hong Kong 502
Santa Clara 408
Woodbridge 362
Houston 353
Wilmington 348
Seattle 328
Ann Arbor 299
Princeton 285
Cambridge 258
Dublin 252
Beijing 248
Boardman 206
Dong Ket 203
Abidjan 166
Hefei 160
New York 157
Bologna 145
Los Angeles 140
Jacksonville 133
Lauterbourg 130
Lomé 130
Westminster 116
Tokyo 114
Nanjing 110
Bremen 108
Padova 108
Turin 103
Berlin 98
Sofia 98
Da Nang 97
Amman 90
Milan 84
Frankfurt am Main 79
Abeokuta 77
Helsinki 77
Dallas 76
Buffalo 68
Haiphong 67
Munich 67
Redondo Beach 58
Saint Petersburg 56
San Diego 54
Seoul 54
Bern 52
Changsha 50
Guangzhou 49
Brussels 45
Shenyang 44
Jinan 43
Johannesburg 40
Medford 40
Turku 40
Nanchang 39
Dearborn 38
Shanghai 38
Hebei 35
The Dalles 34
Biên Hòa 32
Can Tho 31
São Paulo 31
London 30
Yubileyny 30
Jiaxing 28
Phoenix 28
Pune 28
Tianjin 28
Falkenstein 27
Mülheim 27
Toronto 27
Quận Bình Thạnh 26
Rome 26
Warsaw 26
Council Bluffs 25
Paris 24
Zhengzhou 24
Florence 23
Orem 23
Thái Nguyên 23
Norwalk 22
Chicago 21
Olalla 21
Shenzhen 21
Mountain View 20
Düsseldorf 19
Ha Long 19
Lanzhou 19
Redmond 19
Atlanta 18
Falls Church 18
Nuremberg 18
Washington 18
Amsterdam 17
Totale 15.243
Salva come PNG Salva come JPEG
Nome #
Cystatin C and Cardiovascular Risk 350
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 278
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 265
The role of the vascular surgeon in transcatheter aortic valve implantation 260
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 254
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 247
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 245
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 232
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 230
Carbon dioxide coronary angiography: A mechanical feasibility study with a cardiovascular simulator 230
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 228
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 224
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 222
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 221
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 220
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 214
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 210
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 210
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 207
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 203
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 203
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 201
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 200
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 198
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 195
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 195
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 194
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 192
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 191
[Cystatin C and cardiovascular risk. 190
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 190
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 190
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 188
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 188
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 186
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 185
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 184
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 184
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 183
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 183
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 183
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 179
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 177
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 177
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 177
Cistatina C and rischio cardiovascolare 176
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 176
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 176
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 176
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 175
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 174
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 173
Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes 172
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 171
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 171
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 170
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 170
Movement compensation during carbon dioxide coronary angiography: In-vitro validation 170
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 169
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 168
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 168
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 168
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 167
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 166
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 166
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 163
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 162
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 162
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 161
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 160
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 159
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 159
A rescue transcatheter solution for early sutureless basal ring infolding 158
Cystatin C and cardiovascular risk. 158
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 158
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 157
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 157
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 157
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 155
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 155
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 154
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 154
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 154
Effect of cerebrovascular disease on long-term outcome of patients with acute coronary syndromes: findings from a large cohort of unselected patients 153
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 153
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 152
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 152
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 151
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 151
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 151
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 150
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 149
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 149
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 147
Correlation between aortic root dimension and coronary ectasia 147
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 145
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 145
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 144
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 143
Totale 18.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 0 0 0 0 0 63 546
2021/20222.491 200 120 145 222 204 120 49 193 85 188 518 447
2022/20233.267 268 458 176 450 268 267 77 179 593 83 281 167
2023/2024985 70 125 49 117 86 309 35 54 21 60 30 29
2024/20253.480 196 484 303 280 532 188 169 103 56 319 130 720
2025/20268.173 1.060 687 601 604 847 406 887 359 1.789 722 211 0
Totale 24.296